Patent foramen ovale closure versus drug therapy in patients over 60 years and a follow‐up of 5 years
Key Points:
- Compares PFO closure with medication therapy in older patients.
- Analyzes stroke recurrence, complications, and long-term benefits over five years.
- Aims to guide treatment decisions for stroke prevention in elderly patients.
Description
This study compares patent foramen ovale (PFO) closure with drug therapy in patients over 60 years old, assessing long-term outcomes over a five-year follow-up. The research aims to determine the most effective approach in reducing stroke recurrence and improving patient prognosis.
Be the first to review “Patent foramen ovale closure versus drug therapy in patients over 60 years and a follow‐up of 5 years”
Reviews
There are no reviews yet.